Does EMPAGLIFLOZIN Cause Off label use? 787 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 787 reports of Off label use have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 2.1% of all adverse event reports for EMPAGLIFLOZIN.
787
Reports of Off label use with EMPAGLIFLOZIN
2.1%
of all EMPAGLIFLOZIN reports
25
Deaths
279
Hospitalizations
How Dangerous Is Off label use From EMPAGLIFLOZIN?
Of the 787 reports, 25 (3.2%) resulted in death, 279 (35.5%) required hospitalization, and 49 (6.2%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 787 reports have been filed with the FAERS database.
What Other Side Effects Does EMPAGLIFLOZIN Cause?
Diabetic ketoacidosis (3,644)
Fungal infection (1,941)
Blood glucose increased (1,797)
Euglycaemic diabetic ketoacidosis (1,769)
Weight decreased (1,661)
Urinary tract infection (1,439)
Ketoacidosis (1,411)
Dizziness (1,372)
Nausea (1,333)
Vomiting (1,201)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which EMPAGLIFLOZIN Alternatives Have Lower Off label use Risk?
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN
EMPAGLIFLOZIN vs EMSAM
EMPAGLIFLOZIN vs EMTRICITABINE